| Catalog_no |
ADMC0783 |
| Product_name |
Altiratinib(DCC-2701) |
| Category |
抑制剂与激动剂 |
| Size |
10mg/50mg/100mg |
| Price |
5560.00/16660.00/23340.00 |
| Specificity |
Target: c-Met/HGFR . Fields: Altiratinib is a MET/TIE2/VEGFR2/TRK (A,B,C) kinase inhibitor in Phase 1 clinical development for the treatment of invasive solid tumors including glioblastoma. |
| Purification |
>98% |
| Concentration |
靶点：c-Met/HGFR;IC50：No data |
| Storage_stability |
2 years -20°C Powder, 2 weeks4°C in DMSO,6 months-80°C in DMSO |
| othername |
Altiratinib, DCC2701,DCC 2701 |
| Molecular Weight |
510.15 |
| Notes |
Altiratinib is a MET/TIE2/VEGFR2/TRK (A,B,C) kinase inhibitor in Phase 1 clinical development for the treatment of invasive solid tumors including glioblastoma. |
| Instructions |
 查看与下载 |
